**EVENTO AO VIVO!!**

==== NECESSÁRIO LOGIN PARA ASSISTIR A AULA====

*ESTE EVENTO POSSUI PONTUAÇÃO NO CNA

**CERTIFICADOS SÓ SERÃO DISPONIBILIZADOS PARA AQUELES QUE FIZEREM LOGIN E RESPONDEREM A PESQUISA DE SATISFAÇÃO**
***SÓ SERÃO EMITIDOS CERTIFICADOS PARA AQUELES QUE ASSISTIREM AO VIVO***


Data: 13 e 14/11
Horário: 19h00 ás 20h30
Tema: Highlights do AHA

Programação:

Dia 13/11
*Semaglutide and Cardiovascular Outcomes in Patients With Overweight or Obesity Who Do Not Have Diabetes
*DAPA-MI - A Registry-Based Randomized Trial of Dapagliflozin in Patients With Acute Myocardial Infarction Without Diabetes
*Sodium-Glucose Cotransporter-2 Inhibitors in Transthyretin Amyloid Cardiomyopathy
*Apixaban for the Prevention of Stroke in Patients With Subclinical Atrial Fibrillation ARTESiA Study
*Percutaneous Coronary Intervention for Stable Angina (ORBITA-2): A Randomised, Placebo-Controlled Trial


Dia 14/11
*PCI or CABG versus Medical Therapy in the ISCHEMIA Trial: A Post Hoc Analysis
*Effects of Dietary Sodium on Systolic Blood Pressure in Middle-Aged Individuals: A Randomized Order Cross-Over Trial
*Screening for Peripartum Cardiomyopathies Using an Artificial Intelligence Enhanced Digital Stethoscope: A Randomized Clinical Trial
*Artificial Intelligence Enabled Rapid Identification of ST-Elevation Myocardial Infarction Using Electrocardiogram (ARISE): A Pragmatic Randomized Controlled Trial
*Sustained Blood Pressure Reduction With the RNA Interference Therapeutic Zilebesiran: Primary Results From KARDIA-1, a Phase 2 Study in Patients With Hypertension